Tamir Biotechnology Inc. (ACEL)

[Perris]

ACEL Team Receives Prestigious Reward

The Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research at the American Association for Cancer Research (AACR) Annual Meeting in San Diego.
We are pleased to inform you that Michele Carbone, M.D., Ph.D., Alfacell’s chairman of the thoracic cancer advisory board (TCAB) and a world-renowned mesothelioma researcher at the University of Hawaii’s Cancer Research Center of Hawaii, Harvey I. Pass, M.D., a member of Alfacell’s TCAB and a professor of surgery and chief of the division of thoracic surgery and thoracic oncology at NYU School of Medicine and Comprehensive Cancer Center, and their team, were presented The Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research at the American Association for Cancer Research (AACR) Annual Meeting in San Diego.
The team of international collaborators has discovered a unique mesothelioma epidemic in three Turkish villages and has demonstrated that it is caused by a genetic predisposition to mineral fiber carcinogenesis, a gene-environment interaction. These findings and additional research may be applied to understand other geographic areas and communities worldwide to help prevent this deadly form of cancer and help find new life-saving treatments.

The AACR INNOVATOR grant (two-year $100,000 grant) will be applied to additional research for their study.

We, here at Alfacell, congratulate Drs. Carbone and Pass, and their team on receiving this prestigious award and look forward to their continued support with research on the ONCONASE® (ranpirnase) program and mesothelioma.

Please access the news release by going to: http://www.aacr.org/home/public--media/news-releases.aspx?d=1027



Lawrence A. Kenyon

COO and CFO

Alfacell Corporation